3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
43
Phase 1/2
21
Phase 2
15
Phase NA
14
Phase EARLY_PHASE1
6
Phase 4
1
Phase 3
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
52
Gynecologic
2
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Genitourinary
1
CNS
1
Conditions
Sarcoma
10
Osteosarcoma
5
Bone Neoplasms
5
Neurofibrosarcoma
3
Neoplasms
3
Lung Neoplasms
3
Liposarcoma
3
Leiomyosarcoma
3
Sarcoma, Synovial
2
Sarcoma, Ewing
2
Sarcoma, Alveolar Soft Part
2
Nerve Sheath Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Histiocytoma, Malignant Fibrous
2
Gliosarcoma
2
Gastrointestinal Stromal Tumors
2
Fibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Urogenital Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Sezary Syndrome
1
Sarcoma, Clear Cell
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
capmatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Stomach Neoplasms
×
Sarcoma
×
Clear all
NCT06988475
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled